Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intravenous Chelators in Lead-Burdened Type 2 Diabetic Nephropathy
Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Summary
Based on previous basic experiments revealing that patients with type 2 diabetic nephropathy exhibit higher blood lead levels than the general population, this study aims to systematically evaluate the impacts of short-term and long-term blood lead exposure on renal function progression in such patients, so as to provide novel epidemiological evidence for clinical intervention.
Official title: A Prospective Study on Intravenous Chelator Therapy for Slowing Renal Function Progression in Patients With Type 2 Diabetic Nephropathy Combined With Lead Burden
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
42
Start Date
2026-08-01
Completion Date
2029-01-01
Last Updated
2026-07-16
Healthy Volunteers
No
Interventions
chelator
Calcium Disodium Edetate Injection